Literature DB >> 23330546

Nuclear receptors in bile acid metabolism.

Tiangang Li1, John Y L Chiang.   

Abstract

Bile acids are signaling molecules that activate nuclear receptors, such as farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, and vitamin D receptor, and play a critical role in the regulation of lipid, glucose, energy, and drug metabolism. These xenobiotic/endobiotic-sensing nuclear receptors regulate phase I oxidation, phase II conjugation, and phase III transport in bile acid and drug metabolism in the digestive system. Integration of bile acid metabolism with drug metabolism controls absorption, transport, and metabolism of nutrients and drugs to maintain metabolic homeostasis and also protects against liver injury, inflammation, and related metabolic diseases, such as nonalcoholic fatty liver disease, diabetes, and obesity. Bile-acid-based drugs targeting nuclear receptors are in clinical trials for treating cholestatic liver diseases and fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23330546      PMCID: PMC3676171          DOI: 10.3109/03602532.2012.740048

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  95 in total

1.  The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

Authors:  Serge J L B Zweers; Klaske A C Booij; Mina Komuta; Tania Roskams; Dirk J Gouma; Peter L M Jansen; Frank G Schaap
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

2.  ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).

Authors:  T Hirohashi; H Suzuki; H Takikawa; Y Sugiyama
Journal:  J Biol Chem       Date:  2000-01-28       Impact factor: 5.157

3.  Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice.

Authors:  Masaaki Miyata; Yumi Sakaida; Hitomi Matsuzawa; Kouichi Yoshinari; Yasushi Yamazoe
Journal:  Biol Pharm Bull       Date:  2011       Impact factor: 2.233

Review 4.  Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.

Authors:  Geoffrey Porez; Janne Prawitt; Barbara Gross; Bart Staels
Journal:  J Lipid Res       Date:  2012-05-01       Impact factor: 5.922

5.  Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice.

Authors:  Bo Kong; Li Wang; John Y L Chiang; Youcai Zhang; Curtis D Klaassen; Grace L Guo
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

Review 6.  Hepatic transport of bile salts.

Authors:  G A Kullak-Ublick; B Stieger; B Hagenbuch; P J Meier
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

7.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

8.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

Review 9.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

10.  beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes.

Authors:  Jyoti Sinha; Frank Chen; Tamir Miloh; Robert C Burns; Zhisheng Yu; Benjamin L Shneider
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-04       Impact factor: 4.052

View more
  55 in total

1.  Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.

Authors:  Johannes Schmitt; Bo Kong; Grace L Guo; Andreas Geier; Bruno Stieger; Oliver Tschopp; Simon M Schultze; Monika Rau; Achim Weber; Beat Müllhaupt
Journal:  Liver Int       Date:  2014-02-07       Impact factor: 5.828

2.  Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation.

Authors:  Yuan Tian; Jingwei Cai; Wei Gui; Robert G Nichols; Imhoi Koo; Jingtao Zhang; Mallappa Anitha; Andrew D Patterson
Journal:  Drug Metab Dispos       Date:  2018-11-08       Impact factor: 3.922

3.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 4.  Hypothalamic-autonomic control of energy homeostasis.

Authors:  Patricia Seoane-Collazo; Johan Fernø; Francisco Gonzalez; Carlos Diéguez; Rosaura Leis; Rubén Nogueiras; Miguel López
Journal:  Endocrine       Date:  2015-06-19       Impact factor: 3.633

Review 5.  Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability.

Authors:  Pallavi Kompella; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2019-06-05       Impact factor: 4.784

6.  Bile Acid Receptors and Gastrointestinal Functions.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Liver Res       Date:  2019-01-14

7.  Identification and characterization of a novel PPARα-regulated and 7α-hydroxyl bile acid-preferring cytosolic sulfotransferase mL-STL (Sult2a8).

Authors:  Lu Feng; Yee-Lok Yuen; Jian Xu; Xing Liu; Martin Yan-Chun Chan; Kai Wang; Wing-Ping Fong; Wing-Tai Cheung; Susanna Sau-Tuen Lee
Journal:  J Lipid Res       Date:  2017-04-25       Impact factor: 5.922

Review 8.  Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome.

Authors:  Richard C Strange; Kate E Shipman; Sudarshan Ramachandran
Journal:  World J Diabetes       Date:  2015-07-10

Review 9.  The cholangiocyte primary cilium in health and disease.

Authors:  Adrian P Mansini; Estanislao Peixoto; Kristen M Thelen; Cesar Gaspari; Sujeong Jin; Sergio A Gradilone
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-15       Impact factor: 5.187

Review 10.  The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery.

Authors:  Farnaz Fouladi; James E Mitchell; Joseph A Wonderlich; Kristine J Steffen
Journal:  Obes Surg       Date:  2016-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.